Kvols LK - Search Results

1

A phase II study of recombinant human alpha-interferon in advanced hormone-refractory prostate cancer.

van Haelst-Pisani CM, Richardson RL, Su J, Buckner JC, Hahn RG, Frytak S, Kvols LK, Burch PA. van Haelst-Pisani CM, et al. Among authors: kvols lk. Cancer. 1992 Nov 1;70(9):2310-2. doi: 10.1002/1097-0142(19921101)70:9<2310::aid-cncr2820700916>3.0.co;2-4. Cancer. 1992. PMID: 1382829 Clinical Trial.

2

Synchronous and metachronous bilateral testicular tumors. Mayo Clinic experience.

Patel SR, Richardson RL, Kvols L. Patel SR, et al. Cancer. 1990 Jan 1;65(1):1-4. doi: 10.1002/1097-0142(19900101)65:1<1::aid-cncr2820650103>3.0.co;2-5. Cancer. 1990. PMID: 2293856

3

A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.

Patel SR, Kvols LK, Hahn RG, Windschitl H, Levitt R, Therneau T. Patel SR, et al. Among authors: kvols lk. Cancer. 1990 Aug 15;66(4):655-8. doi: 10.1002/1097-0142(19900815)66:4<655::aid-cncr2820660409>3.0.co;2-p. Cancer. 1990. PMID: 2201425 Clinical Trial.

4

Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant disease.

Creagan ET, Frytak S, Long HJ, Kvols LK. Creagan ET, et al. Among authors: kvols lk. Cancer. 1989 Sep 1;64(5):1034-7. doi: 10.1002/1097-0142(19890901)64:5<1034::aid-cncr2820640512>3.0.co;2-a. Cancer. 1989. PMID: 2474365

5

Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon.

Edmonson JH, Kovach JS, Buckner JC, Kvols LK, Hahn RG. Edmonson JH, et al. Among authors: kvols lk. Cancer Res. 1988 Nov 15;48(22):6584-6. Cancer Res. 1988. PMID: 3141046

6

A phase I clinical trial of recombinant human tumor necrosis factor.

Creagan ET, Kovach JS, Moertel CG, Frytak S, Kvols LK. Creagan ET, et al. Among authors: kvols lk. Cancer. 1988 Dec 15;62(12):2467-71. doi: 10.1002/1097-0142(19881215)62:12<2467::aid-cncr2820621202>3.0.co;2-5. Cancer. 1988. PMID: 3191449

7

A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors.

Ansell SM, Pitot HC, Burch PA, Kvols LK, Mahoney MR, Rubin J. Ansell SM, et al. Among authors: kvols lk. Cancer. 2001 Apr 15;91(8):1543-8. doi: 10.1002/1097-0142(20010415)91:8<1543::aid-cncr1163>3.0.co;2-n. Cancer. 2001. PMID: 11301403 Clinical Trial.

8

Observation after orchiectomy in clinical stage I nonseminomatous germ cell tumor of testis. Mayo Clinic experience.

Patel SR, Richardson RL, Kvols L, Zincke H. Patel SR, et al. Am J Clin Oncol. 1990 Oct;13(5):379-81. doi: 10.1097/00000421-199010000-00003. Am J Clin Oncol. 1990. PMID: 2171316

9

Metastatic cancer to the testes: a report of 20 cases and review of the literature.

Patel SR, Richardson RL, Kvols L. Patel SR, et al. J Urol. 1989 Oct;142(4):1003-5. doi: 10.1016/s0022-5347(17)38969-3. J Urol. 1989. PMID: 2677407 Review.

10

Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.

O'Connell MJ, Rubin J, Hahn RG, Kvols LK, Moertel CG. O'Connell MJ, et al. Among authors: kvols lk. Cancer Treat Rep. 1987 Mar;71(3):333-4. Cancer Treat Rep. 1987. PMID: 3815402 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters